Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Completed

Conditions studied: Hepatitis B

In brief

This registry will remain open for approximately 5 years (4 years of enrollment + 1 year of follow up). Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of liver decompensation, death, or conclusion of the registry.

Key facts

Study ID
NCT01590615
Run by
Gilead Sciences
People needed
54
Starts
2012-04-26
Expected to finish
2017-04-04
Last updated by the study team
2017-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.